Healthcare - Biotechnology - NYSE - US
$ 15.7
-0.444 %
$ 1.44 B
Market Cap
-4.92
P/E
BALANCE SHEET
1.1 B
ASSETS
633 M
LIABILITIES
462 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Arcus Biosciences, Inc.
| Current Assets | 831 M |
| Cash & Short-Term Investments | 759 M |
| Receivables | 42 M |
| Other Current Assets | 30 M |
| Non-Current Assets | 264 M |
| Long-Term Investments | 107 M |
| PP&E | 51 M |
| Other Non-Current Assets | 106 M |
| Current Liabilities | 184 M |
| Accounts Payable | 17 M |
| Short-Term Debt | 11 M |
| Other Current Liabilities | 156 M |
| Non-Current Liabilities | 449 M |
| Long-Term Debt | 0 |
| Other Non-Current Liabilities | 449 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Cash & Cash Equivalents | 127.0 | 206.0 | 147.9 | 173.4 | 57.9 | 71.1 | 98.4 | 65.2 |
| Short Term Investments | 632.0 | 803.0 | 351.4 | 555.2 | 130.3 | 185.5 | 77.3 | 33.7 |
| Receivables | 42.0 | 43.0 | 745.0 | 1.7 | 0.1 | 83 K | 25 K | 0.4 |
| Inventory | 0 | (172.0) | (762.4) | (7.2) | 0 | 0 | 0 | 0 |
| Other Current Assets | 30.0 | 15.0 | 16.0 | 1.0 | 4.3 | 2.3 | 1.1 | 0.4 |
| Total Current Assets | 831.0 | 1 067.0 | 681.3 | 735.1 | 192.7 | 258.9 | 176.9 | 99.7 |
| PP&E | 51.0 | 35.0 | 137.4 | 23.6 | 9.3 | 11.1 | 11.2 | 8.6 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 107.0 | 129.0 | 182.0 | 6.4 | 0.2 | 4.4 | 0.7 | 1.0 |
| Other Long Term Assets | 106.0 | 114.0 | 591.2 | 7.2 | 0.9 | 0.5 | 1.7 | 0.4 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 1 095.0 | 1 345.0 | 1 591.9 | 772.3 | 203.1 | 274.9 | 190.5 | 109.7 |
| LIABILITIES | ||||||||
| Accounts Payable | 17.0 | 20.0 | 10.3 | 15.7 | 4.7 | 3.1 | 3.8 | 3.9 |
| Short Term Debt | 11.0 | 3.0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 65.0 | 73.0 | 52.0 | 31.4 | 11.0 | 7.6 | 3.9 | 1.7 |
| Total Current Liabilities | 184.0 | 193.0 | 166.1 | 121.7 | 22.7 | 16.9 | 12.7 | 5.5 |
| Long Term Debt | 0 | 0 | 116.9 | 15.2 | 0 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | (117.0) | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 142.0 | 140.0 | 5.3 | 10.2 | 4.5 | 6.1 | 5.3 | 4.7 |
| Total Liabilities | 633.0 | 688.0 | 750.4 | 270.0 | 39.3 | 40.0 | 36.6 | 10.2 |
| EQUITY | ||||||||
| Common Stock | 1 311.0 | 1 206.0 | 7 K | 6 K | 4 K | 4 K | 3 K | 1 K |
| Retained Earnings | (849.0) | (542.0) | (275.4) | (328.2) | (205.3) | (122.8) | (73.2) | (20.2) |
| Other Accumulative Comprehensive Income/Loss | 0 | (7.0) | (1.3) | 44 K | 64 K | (0.1) | 42 K | 26 K |
| Total Equity | 462.0 | 657.0 | 841.5 | 502.3 | 163.8 | 234.9 | 153.9 | 99.5 |
| Total Liabilities and Equity | 1 095.0 | 1 345.0 | 1 591.9 | 772.3 | 203.1 | 274.9 | 190.5 | 109.7 |
| SHARES OUTSTANDING | ||||||||
| Common Shares Outstanding | 74.0 | 72.0 | 69.3 | 54.8 | 43.8 | 34.6 | 42.6 | 24.6 |